KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Income from Non-Controlling Interests (2019 - 2020)

Historic Income from Non-Controlling Interests for Inovio Pharmaceuticals (INO) over the last 9 years, with Q2 2020 value amounting to -$469407.0.

  • Inovio Pharmaceuticals' Income from Non-Controlling Interests fell 14467.4% to -$469407.0 in Q2 2020 from the same period last year, while for Mar 2021 it was -$469407.0, marking a year-over-year increase of 7266.6%. This contributed to the annual value of -$1.1 million for FY2020, which is 1080.04% up from last year.
  • Latest data reveals that Inovio Pharmaceuticals reported Income from Non-Controlling Interests of -$469407.0 as of Q2 2020, which was down 14467.4% from -$594350.0 recorded in Q1 2020.
  • Over the past 5 years, Inovio Pharmaceuticals' Income from Non-Controlling Interests peaked at -$69605.0 during Q1 2019, and registered a low of -$594350.0 during Q1 2020.